FDA Issues recall of Endocet

The FDA has announced a recall of Endocet, a painkiller with active ingredients found in OxyContin and Tyolenol due to pills being produced of the wrong dosage.  The recall included two lots of pills being removed from the market.

The FDA initiated the recall after it was discovered that bottles had been produced with pills containing much more powerful doses of acetaminophen, which is the active ingredient in Tylenol, than had been advertised on the bottle of Endocel.  The pills in question were different in size and shape than the pills that were supposed to be in the bottles.

The Endocet bottles were supposed to contain tablets consisting of 325mg acetaminophen and 10mg oxycodone, however some tablets contained 650mg of acetaminophen.

The FDA recall affects Endocet bottles containing 100 10mg oxycodone/325mg acetaminophen tablets with lot numbers 402415NV and 402426NV with an expiration date of January 2014, distributed in Arizona, California, Colorado, New York, Ohio, North Dakota, Illinois, Kentucky, New Hampshire, New Jersey, Louisiana, North Carolina, Missouri, Pennsylvania, Florida, Tennessee and Puerto Rico.

Endo Pharmaceuticals (the manufacturer of Endocet) claims to currently be I the process of notifying all customers who may have received the pills in order to arrange for the products return.

Contact a drug recall attorney today if you have any questions or concerns over this or any other drug recall you may potentially be affected by. 


About the Contributor

Related Posts